9106.5000 -182.00 (-1.96%)
NSE Jul 10, 2025 13:30 PM
Volume: 18,288
 

9106.50
-1.96%
AstraZeneca covid-19 antibody treatment suffers setback
livemint
Drug's efficacy as post-infection therapy falls short in clinical trial, but potential preventative use is still undergoing testing
More from AstraZeneca Pharma India Ltd.
Recommended